Journal
JOURNAL OF CYSTIC FIBROSIS
Volume 10, Issue -, Pages S29-S36Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S1569-1993(11)60006-4
Keywords
Cystic fibrosis; Liver disease; Liver biopsy; Esophageal varices; Ultrasonography; Ursodeoxycholic acid
Categories
Funding
- European Union [LSHM-CT-2005-018932]
Ask authors/readers for more resources
Approximately 5-10% of cystic fibrosis (CF) patients develop multilobular cirrhosis during the first decade of life. Most CF patients later develop signs of portal hypertension with complications, mainly variceal bleeding. Liver failure usually occurs later, after the paediatric age. Annual screening for liver disease is recommended to detect pre-symptomatic signs and initiate ursodeoxycholic acid therapy, which might halt disease progression. Liver disease should be considered if at least two of the following variables are present: abnormal physical examination, persistently abnormal liver function tests and pathological ultrasonography. If there is diagnostic doubt, a liver biopsy is indicated. All CF patients with liver disease need annual follow-up to evaluate the development of cirrhosis, portal hypertension or liver failure. Management should focus on nutrition, prevention of bleeding and variceal decompression. Deterioration of pulmonary function is an important consideration for liver transplantation, particularly in children with hepatic dysfunction or advanced portal hypertension. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available